Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice

SCCA's Petros Grivas, MD, PhD, is lead author in an article reviewing avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma.

Read the Uro Today Article